Friday, December 11, 2009
Gilead drug aids cystic fibrosis: US FDA panel - TopNews United States
TopNews United States
Gilead drug aids cystic fibrosis: US FDA panel
TopNews United States
Shares of Gilead rose by 4 cents to $46.33 in after-hours trading after rising by 29 cents to close at $46.29 during the regular trading session.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment